| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6201163 | Ophthalmology | 2015 | 7 Pages |
Abstract
Significant improvements in CFS and patient symptomatology after DED treatment were evident only in the subgroup with near-normal corneal SNFL. Consideration of SNFL may assist in explaining the variability of patients' response to DED therapy.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Ahmad MD, Thomas H. MD, Francisco MD, Michael A. MD, Arsia MD, MPH, Pedram MD, Reza MD, MPH, MSc,